Read More Biotech General Health Care Large Cap News Merck’s Two Keytruda Combo Cancer Trials Miss Primary Goal By Vandana Singh August 3, 8:53 AM Merck & Co Inc’s (NYSE:MRK) Phase 3 KEYNOTE-921 trial of Keytruda combined with chemotherapy (docetaxel) did not meet its dual… ESALF
Read More Biotech General News New Research Demonstrates 2.3 Point Reduction In HbA1c For Dario Digital Health Users With Baseline HbA1c Greater Than 9 points By Happy Mohamed June 26, 8:32 AM Retrospective cohort study presented at the American Diabetes Association 83rd Scientific Sessions analyzed real-world data of Dario users against matched controls to demonstrate a greater reduction when compared to DRIO
Read More Analyst Ratings News Price Target Keybanc Maintains Underweight on Westlake, Raises Price Target to $95 By Benzinga Newsdesk January 12, 5:41 AM Keybanc analyst Aleksey Yefremov maintains Westlake (NYSE:WLK) with a Underweight and raises the price target from $85 to $95. WLK
Read More Equities Movers News Trading Ideas Tesla Stock Poised To Extend 13-Session Winning Streak: What’s Driving The Rally By Shanthi Rexaline June 14, 6:54 AM Tesla, Inc. (NASDAQ:TSLA) shares advanced in premarket trading on Wednesday as the upward momentum stays intact. Heading into… F